Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
6,443 total articles
Cal-Maine bought Creighton Brothers for $128.5M, adding 3.2M laying hens and processing capacity. The market has reacted, but valuation metrics - P/E ~5.3, EV/EBITDA ~3.4 and EV/Sales <1 - suggest the acquisition's earnings and strategic benefits are not fully priced. This is a position-sized long with defined entry, stop and target and a 120-tradi…
UBTRF printed a clean technical and sentiment setup after a stronger-than-expected update. Price sits above near-term EMAs, MACD shows bullish momentum, and short interest has spiked — creating a two-way opportunity. This is a tactical mid-term long for disciplined traders who accept OTC liquidity and execution risk.
Robert Half is paying a near-10% yield today while generating roughly $267M in free cash flow and carrying minimal reported debt. The business is cyclical, but recent sequential improvement in talent solutions and a large Protiviti consulting franchise give upside if hiring stabilizes. This trade idea outlines an entry at $24.00, a conservative sto…
CoreWeave has a fresh run of positive updates and continued AI demand that justify upgrading to a core long. The stock still trades well below its 52-week high, and fundamentals show massive growth but also heavy leverage. This trade idea lays out a pragmatic entry at $88.83, a $130 target on a 180-trading-day horizon, and a $72 stop to balance ups…
Archer (ACHR) is trading near its 52-week low after execution and production disappointments, but the stock already prices in a lot of bad news. With FAA compliance milestones, an emerging path to initial revenue via planned taxi networks, and an enterprise value below market cap implying net cash, I see a high-upside trade for patient, disciplined…
Nvidia’s $2 billion investment in Marvell and expanded NVLink Fusion partnership materially derisks Marvell’s role in AI data center stacks. With a $100B market cap, solid free cash flow and a visible path to ~40% data-center revenue growth in fiscal 2027, Marvell offers asymmetric upside. This trade outlines an entry at $114.45, a stop at $98.00 a…
Dave is trading at a reasonable multiple given accelerating membership growth, rising profitability and a planned AI-driven product push. The company prints strong cash flow, low leverage and recently added senior AI talent to the board. This trade idea outlines a long position with specific entry, stop and target alongside a balanced risk framewor…
Rigel Pharmaceuticals has shifted from a sleepy clinical-stage name to a company with meaningful commercial traction. Large product sales and a strategic collaboration pushed revenue sharply higher in 2025, valuation multiples look reasonable relative to cash generation, and technicals and short interest set up a tradeable long. This idea lays out …
Exail Technologies is showing breakout characteristics: price above the 10/20/50 SMAs, rising volume, and sustained short interest that can amplify moves. This trade idea outlines a constructive long with a clear entry at $144.52, a stop at $125.00 and a primary target of $175.00 over a long-term (180 trading days) horizon.
Capstone Copper appears discounted on short-term worries while fundamentals tied to rising structural copper demand and the company's low-cost assets argue for upside. This actionable trade plan lays out entry, stop and target with a mid-term horizon and explicit risk management.
The sudden U.S.-Iran ceasefire that sent crude down ~15% on 04/08/2026 exposed a near-term earnings vulnerability for integrated oil majors. ExxonMobil's shares are trading off the rally high and technical momentum is slipping. We propose a tactical short over the next 10 trading days to capture downside if oil remains depressed and the market re-r…
Innodata has shifted from legacy data services into a high-growth AI data engineering business. Revenue expansion and improving margins make the stock a reasonable tactical long, but the company's current valuation - a P/E north of 40 and EV/sales near 4.7 - leaves little room for execution slippage. This trade plan targets $60 with a $34 stop over…
Archer Aviation is a pre-revenue eVTOL developer that has seen its valuation compress after missed production targets and hefty 2025 losses. The company carries FAA momentum for its Midnight airframe and plans to launch taxi networks, and the stock is trading near recent lows with bullish technicals and heavy liquidity. This trade idea lays out a m…
United Airlines looks like a high-probability swing trade after the market priced in a two-week U.S.-Iran ceasefire and a sharp drop in crude. The stock is trading on attractive valuation multiples (P/E ~8.7, EV/EBITDA ~6.1) with meaningful free cash flow and a manageable balance-sheet profile for a cyclical recovery. This idea lays out a concrete …
LyondellBasell (LYB) is set to benefit from higher petrochemical and refining spreads after disruptions in the Strait of Hormuz. The stock has retraced from a March rally, offering a mid-term entry into a business with strong free cash flow, a near 6% dividend yield, and an EV/EBITDA of ~16. This trade targets a retracement back toward and above th…
Nano Nuclear Energy (NNE) has retraced roughly 60% from its 2025 highs and is showing renewed volume and bullish momentum signals. With a $1.17B market cap, net cash-like enterprise value, and a near-term cash burn profile that’s been disclosed, this trade idea outlines a mid-term (45 trading days) long with a defined entry, stop and target to capt…
Smartphone unit competition and component cost pressure are capping margins for Xiaomi today. That said, the company’s heavy bets on consumer robotics, home automation, and agentic AI could be a multi-year re-rate catalyst if execution matches ambition. This trade idea sizes a long position to capture upside from product cycle stabilization and AI/…
NewLake Capital Partners yields roughly 12% today yet shows tangible AFFO coverage, $106.3M of liquidity and a concentrated but cash-generating cannabis real estate portfolio. This trade idea lays out an actionable long with precise entry, stop and target, plus the catalysts and risks that matter.
Apple's hardware-software stack and massive installed base make it a pragmatic infrastructure beneficiary of local AI adoption. With a $3.8T market cap, $123.3B in free cash flow, and conservative AI spend positioning, Apple is set to monetize on-device models, chips, and services. This trade idea proposes a long entry at $258.93 with a $245 stop a…
Nvidia is trading like momentum faded, but fundamentals and strategic moves (including a $2B strategic investment in Marvell) point to outsized upside. This trade idea proposes a disciplined long entry at $180.00 with a $235.00 target and a $168.00 stop, sized for a long-term horizon (180 trading days).
TKMS has seen upward estimate revisions from sell-side analysts while the market has pushed shares lower. That divergence creates a risk-defined buying opportunity for disciplined traders. This trade plan lays out entry at $12.25, a conservative stop at $10.50, and staged targets at $15.00 and $18.00 over a 180 trading-day horizon.
UnitedHealth (UNH) just received a material near-term earnings tailwind from CMS Medicare Advantage rate increases. The stock has started to reprice, momentum indicators are bullish, and valuation still has room to expand versus recent troughs. This trade idea outlines an entry at $305.93, a stop at $292.00 and a $360 target on a mid-term (45 tradi…
Rivian is transitioning from a pure-play hardware EV maker to a software-defined vehicle platform with meaningful upside if execution on R2, Uber autonomous commitments, and software/services monetization accelerate. Valuation at ~3.4x sales already prices some growth; the trade targets a mid-term re-rating while acknowledging cash burn and executi…
GLD has pulled back from the January peak and is trading near the mid-point of its recent range. With easing Fed expectations, central bank demand and geopolitical shocks keeping safe-haven flows alive, I recommend a tactical long in GLD with defined entry, stop and target for a 180-trading-day trade.
Structure Therapeutics (GPCR) reported Phase 2 results showing placebo-adjusted weight loss in the mid-teens at 44 weeks for aleniglipron, an oral GLP-1 receptor agonist. The data position the drug as best-in-class among oral options and competitive with injectables. With a market cap near $3.8B, meaningful cash on the balance sheet and a planned P…
